Back to top
more

Align Technology (ALGN)

(Real Time Quote from BATS)

$136.76 USD

136.76
1,302,358

-2.89 (-2.07%)

Updated Aug 6, 2025 03:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.

Sweta Killa headshot

7 Inverse ETFs Riding High on Nasdaq Sell-Off

by Sweta Killa

We have highlighted seven inverse ETFs that benefited the most from the Nasdaq sell-off.

Zacks Equity Research

Stock Market News for May 11, 2021

by Zacks Equity Research

Benchmarks closed in the red on Monday as inflation jitters moved investors away from stocks sensitive to economic reopening

Zacks Equity Research

Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Align Technology (ALGN) closed the most recent trading day at $582.15, moving -2.94% from the previous trading session.

Zacks Equity Research

XRAY vs. ALGN: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

XRAY vs. ALGN: Which Stock Is the Better Value Option?

Zacks Equity Research

Align Technology (ALGN) Q1 Earnings Beat Estimates, Margins Up

by Zacks Equity Research

Align Technology's (ALGN) segments report solid Q1 sales across geographies despite the pandemic-led business challenges.

Zacks Equity Research

Align Technology (ALGN) Beats Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Align Technology (ALGN) delivered earnings and revenue surprises of 25.13% and 8.54%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Product Stocks' Earnings on Apr 28: BSX, ALGN & More

by Urmimala Biswas

The sector's Q1 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

Zacks Equity Research

Why the Earnings Surprise Streak Could Continue for Align Technology (ALGN)

by Zacks Equity Research

Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

by Zacks Equity Research

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Align Technology (ALGN) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Align Technology (ALGN) is expected to have gained from robust Invisalign aligners and iTero scanners shipment volume in Q1.

Zacks Equity Research

Here's Why You Should Retain AmerisourceBergen (ABC) Stock

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.

Zacks Equity Research

Intuitive Surgical (ISRG) Q1 Earnings & Revenues Top Estimates

by Zacks Equity Research

Intuitive Surgical's (ISRG) first-quarter results reflect strong segmental performance.

Zacks Equity Research

Edwards Lifesciences (EW) Beats on Q1 Earnings, Margins Down

by Zacks Equity Research

Despite coronavirus-led business challenges, Edwards Lifesciences (EW) witnessed robust segmental performances in Q1.

Zacks Equity Research

Integra (IART) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

Integra (IART) is optimistic about maintaining its strength in its international business, along with its portfolio optimization strategy.

Zacks Equity Research

Here's Why You Should Hold on to LabCorp (LH) Stock Now

by Zacks Equity Research

Investors are optimistic about LabCorp (LH) backed by its strong diagnostic arm growth and progress in Covance business.

Zacks Equity Research

Align Technology (ALGN) Stock Moves -0.43%: What You Should Know

by Zacks Equity Research

Align Technology (ALGN) closed at $603.72 in the latest trading session, marking a -0.43% move from the prior day.

Zacks Equity Research

What Makes Align Technology (ALGN) a Strong Momentum Stock: Buy Now?

by Zacks Equity Research

Does Align Technology (ALGN) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Is (ALGN) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

Align Technology's (ALGN) Shares March Higher, Can It Continue?

by Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Align Technology (ALGN).

Zacks Equity Research

Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about QIAGEN (QGEN) on the back of product launches and impressive geographical growth.

Urmimala Biswas headshot

MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth

by Urmimala Biswas

While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.

Trina Mukherjee headshot

Dental Market Shows Strength Despite Pandemic: 3 Stocks to Watch

by Trina Mukherjee

Let's keep a watch on three lucrative stocks, XRAY, MCK and MMSI, in the dental space that have performed impressively despite the pandemic-led volatility.

Zacks Equity Research

Align Technology (ALGN) Moves to Buy: Rationale Behind the Upgrade

by Zacks Equity Research

Align Technology (ALGN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

XRAY vs. ALGN: Which Stock Is the Better Value Option?

by Zacks Equity Research

XRAY vs. ALGN: Which Stock Is the Better Value Option?

Zacks Equity Research

Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Align Technology (ALGN) closed at $595.63 in the latest trading session, marking a -0.91% move from the prior day.